← 返回

单细胞转录组学揭示 IDH 野生型高级别胶质瘤免疫景观的异质性

英文原题:Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas.

查看英文原题

Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas.

PubMed 2024/02/02(内容时间) Cancer Immunol Res Q1 · IF 7.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

异柠檬酸脱氢酶(IDH)野生型(WT)高级别胶质瘤,尤其是胶质母细胞瘤,具有高度侵袭性且肿瘤微环境免疫抑制。尽管已知肿瘤浸润免疫细胞在胶质瘤发生中发挥关键作用,其异质性及细胞间相互作用仍未充分阐明。

本研究构建了IDH-WT高级别胶质瘤患者肿瘤组织及配对外周血单核细胞(PBMC)中免疫细胞的单细胞转录组图谱。分析鉴定出肿瘤中两个肿瘤相关巨噬细胞(TAM)亚群,其促肿瘤特征最为突出,提示它们可能参与胶质瘤进展。

我们还研究了T细胞分化轨迹,并鉴定出芳香烃受体(AHR)是T细胞功能障碍的调节因子,为胶质瘤免疫治疗提供了潜在靶点。我们进一步证实,敲除AHR可减轻嵌合抗原受体(CAR)T细胞耗竭,并在体外和体内提高CAR-T 细胞抗肿瘤疗效。

最后,我们探究了肿瘤微环境和PBMC中由配体-受体相互作用介导的细胞间通信,揭示了肿瘤微环境内独特的细胞相互作用。综上,本研究提供了IDH-WT高级别胶质瘤的全面免疫图谱,并提出胶质瘤免疫治疗的潜在药物靶点。

展开英文摘要原文

Isocitrate dehydrogenase (IDH)-wild-type (WT) high-grade gliomas, especially glioblastomas, are highly aggressive and have an immunosuppressive tumor microenvironment. Although tumor-infiltrating immune cells are known to play a critical role in glioma genesis, their heterogeneity and intercellular interactions remain poorly understood. In this study, we constructed a single-cell transcriptome landscape of immune cells from tumor tissue and matching peripheral blood mononuclear cells (PBMC) from IDH-WT high-grade glioma patients.

Our analysis identified two subsets of tumor-associated macrophages (TAM) in tumors with the highest protumorigenesis signatures, highlighting their potential role in glioma progression.

We also investigated the T-cell trajectory and identified the aryl hydrocarbon receptor (AHR) as a regulator of T-cell dysfunction, providing a potential target for glioma immunotherapy.

We further demonstrated that knockout of AHR decreased chimeric antigen receptor (CAR) T-cell exhaustion and improved CAR T-cell antitumor efficacy both in vitro and in vivo.

Finally, we explored intercellular communication mediated by ligand-receptor interactions within the tumor microenvironment and PBMCs and revealed the unique cellular interactions present in the tumor microenvironment. Taken together, our study provides a comprehensive immune landscape of IDH-WT high-grade gliomas and offers potential drug targets for glioma immunotherapy.

论文信息

作者
Ran X、Zheng J、Chen L、Xia Z、Wang Y、Sun C、Guo C、Lin P
单位
Westlake Disease Modeling Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.China
文献类型
非美国政府资助研究
期刊
Cancer immunology research2024 Feb 2
原文标识
PubMed 38091354 · DOI 10.1158/2326-6066.CIR-23-0211